Hospital Universitario Puerta Del Mar — Clinical Trial Site

74 Registered trials

30 Currently recruiting

Organisation

Hospital Universitario Puerta Del Mar

Location

Cadiz, Spain

Identifier

ORG-100028569

Address

Avenida De Ana De Viya 21, 11009, Spain

Departments

#2315:servicio de neurología
#5415 :neurologia
#724003: Neurocirugía
2746; Dermatología
3455: Servicio Dermatología
3652: Pediatría
9248: Servicio Dermatología
Cardiología
Cardiology
Departamento de aparato digestivo
Dermatología
Dermatology
Dermatology Medical- Surgical and Venerology
Endocrinología y Nutrición
Endocrinology & Metabolism
Endocrinology and Metabolism
Hematología
Hematology
Hospital Universitario Puerta del Mar
Internal Medicine
Medical Oncology
Microbiología
Nefrología
Nefrology
Neonatology
Nephrology
Neurología
Neurology
None
Obstetrician and Gynecologist
Oncology
Oncology Department
Oncology Service
Ophthalmology
Oral and Maxillofacial Surgery
Pediatrics
Pneumology
Servicio de digestivo
Servicio de Angiología y Cirugía vascular
Servicio de Cardiología
Servicio de Oftalmología
Surgery
UGC Cuidados Intensivos
Urology
Vascular Surgery and Angiology

Clinical trials at this site (74)

Search interface

A Phase 3 extension study to assess the long-term safety and efficacy of remibrutinib in adult participants with moderate to severe hidraden… Pending

2025-523259-72-00 Hidradenitis Suppurativa (HS) 5
A study to investigate dabogratinib (TYRA-300) in participants with Low Grade Upper Tract Urothelial Carcinoma Pending

2025-523539-20-00 Low Grade Upper Tract Urothelial Carcinoma 4
Phase II/III randomized controlled open-label trial to evaluate the efficacy and safety of personalized tissue engineered veins in patients … Pending

2025-524103-69-00 Chronic Venous Insufficiency 10
Optimizing Aspirin Use for Preeclampsia Prevention Pending

2025-524646-94-00 Obstetrics – Preeclampsia 11
A Study of KT-621 Administered Orally to Adult Participants with Moderate to Severe Eosinophilic Asthma Recruiting

2025-523180-38-00 Uncontrolled Moderate to Severe Eosinophilic Asthma 4 2026-05-21
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting

2025-522878-36-00 Chronic Spontaneous Urticaria 5 2026-04-20
A Phase 3 Single-arm Study of UGN-104 for the Treatment of LG-UTUC Recruiting

2024-519343-15-00 Low-grade Upper Tract Urothelial Cancer 5 2025-10-08
Efficacy and safety of 7 versus 14 days of antibiotic treatment for bacteremia produced by Pseudomonas aeruginosa: a multicenter, randomized… Recruiting

2023-508441-41-00 Bacteriemia producida por P. aeruginosa. 6 2024-07-08
A Study of Zanubrutinib Versus Lenalidomide in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma (MAHOGANY) Recruiting

2022-502548-12-00 marginal zone lymphoma 5 2023-09-28
Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasiv… Recruiting

2024-520006-19-00 Non-muscle invasive bladder cancer 6 2021-12-15
LIBRETTO-432: A Placebo-controlled Double-Blinded Randomized Phase 3 Study of Adjuvant Selpercatinib in RET fusion-Positive NSCLC Recruiting

2023-506784-33-00 RET fusion-Positive NSCLC 5 2021-01-19
A study to compare Venetoclax Azacitidine and Quizartinib Vs Venetoclax and Azacitidine in newly diagnosed acute myeloid leukemia patient´s … Recruiting

2025-522979-29-00 Acute myeloid leukemia 5 2026-04-30
A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medic… Recruiting

2025-522705-37-00 HIDRADENITIS SUPPURATIVA 4 2026-04-21
Brivekimig for the treatment of moderate to severe hidradenitis suppurativa Recruiting

2025-522333-61-00 Hidradenitis suppurativa 4 2026-01-23
Clinical Trial of Immune-Guided Prevention of CMV Infection in Low-Risk Kidney Transplantation: INMUNOVIR Study. Recruiting

2025-520742-29-00 Low-risk renal transplant patients 5 2025-12-19
A Phase 3, Randomized, Open-label, Multicenter Study Evaluating the Efficacy and Safety of TAR-210 Erdafitinib Intravesical Delivery System … Recruiting

2024-519493-39-00 High-risk Non-muscle-invasive Bladder Cancer with Susce 5 2025-12-09
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with moderate to severe hid… Recruiting

2025-520564-17-00 Hidradenitis suppurativa (HS) 5 2025-10-16
Reduced Immunosuppression for Older Adult Kidney Transplant Recipients: the RELEASE study. Recruiting

2025-520535-16-00 End-stage renal disease 6 2025-10-10
A phase III, randomized, double blind, multiple doses, placebo-controlled parallel-group, adaptive study to evaluate the efficacy of atropin… Recruiting

2023-510439-13-00 Myopia 5 2025-09-25
Effect of levothyroxine and hypocaloric diet for the treatment of obesity. Recruiting

2024-514377-22-00 Metabolic disease 5 2025-09-04
Phase 3 Study of Ravulizumab versus Placebo in Adult Participants at High Risk of DGF after Kidney Transplantation (AWAKE) Recruiting

2024-517568-48-00 Delayed Graft Function after Kidney Transplantation 5 2025-07-21
A study of IPN10200 for the treatment of cervical dystonia in adults Recruiting

2024-519248-34-00 Cervical Dystonia 4 2025-06-17
Study to evaluate efficacy and safety of inclisiran in children aged 6 to under 12 years of age with heterozygous familial hypercholesterole… Recruiting

2024-514594-21-00 Heterozygous Familial Hypercholesterolemia 5 2025-03-13
A study to assess how Vaborem® is taking up in the body and tolerated in paediatric patients with serious infections. Recruiting

2024-514656-32-00 Suspected or confirmed Gram negative infections 4 2025-01-23